Prevalence of diabetes in north america research

S. Furthermore, the prevalence rate of the condition has more than doubled in the past decades. This study seeks to explore the reason behind the high prevalence rate in the U. S compared to other developed countries. Whereas diabetes type 2 (T2DM) is caused by a complexity of factors, this study argues that industrialization and urbanization have played an integral role in the prevalence of the disease. This bibliography reveals that there is a need for extensive research in this field so as to reduce the knowledge gap on this research issue. Chen, L. , Magliano, D. J. , & Zimmet, P. It brings out clearly this argument by pointing to North America’s industrialization This article is relevant to the topic as it explores the prevalence of diabetes mellitus in the international field.

Included in the article are factors that contribute to the epidemiology of diabetes type 2. The study also covers a range of topics such as the early onset of the disease. It concludes by recognizing the need for further research to understand the factors contributing to T2DM. Hyman MA. The study also points out that evidence of Canadian Aboriginals from great lakes sport fishermen has a higher rate of diabetes as a consequence of eating contaminated food. Based on the evidence presented in the study, the author argues that environmental toxins do interfere with metabolism and can contribute to diabetes T2DM. The article conveys a distinctive message about the need for further research on the connection between environmental toxins and T2DM.

The burden of toxins resulting from the urbanized society places considerable pressure on the metabolism of the body. The author challenges readers to stop and think about the exposure to a significant amount of chemicals and heavy metals released annually as well as our addiction to energy and industrialization. The data analysed was from 1971 to 2004 from North America, with a particular focus on adults from ages 20 to 74 years. The article reveals that not only has the prevalence of the disease doubled in North America, but also affects more of the ethnic minorities compared to their White counterparts. The study revealed that the prevalence of the condition was higher among Blacks and Hispanics. Furthermore, patients with the disease tended to exist in a similar environmental circumstance; for instance, a majority of the patients were from low socioeconomic backgrounds.

Also, the prevalence of the disease among Hispanics was largely associated with obesity. The continual evolution of type 2 diabetes: an update on pathophysiology and emerging treatment options. Therapeutics & Clinical Risk Management, 11, 621–632. https://doi-org. proxy. ccis. If the current progression continues, then approximately 592 million people worldwide will have the condition by 2035. The burden of the disease will cost North America will exceed $500 billion by 2025 (Cornell, 2015). The authors also present what is currently known about the pathophysiology of the condition. According to Cornell, pharmacotherapy has broad benefits in controlling hyperglycemia and cardiovascular risks in patients with T2DM. However, the success of the treatments has to do with early interventions on lifestyle changes. As a consequence, the prevalence of the condition increased in developing countries.